Abstract
In the quest to overcome traditional chemotherapy limitations, this review explores targeted drug delivery via folate receptor-guided nanocarriers and drug conjugates bridging chemical and biomedical perspectives emphasizing brain and breast cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
